Ensysce Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of solutions for severe pain relief while reducing the fear of and the potential for misuse and overdose. The firm's Trypsin Activated Abuse Protection and Multi-Pill Abuse Resistance platforms are in the process of developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. The company was founded in April 2003 and is headquartered in La Jolla, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
9
Frequently Asked Questions
What is Market Cap of Ensysce Biosciences Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Ensysce Biosciences Inc market cap is $4.34M.
What is the 52-week high for Ensysce Biosciences Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Ensysce Biosciences Inc 52 week high is $2.64 as of June 05, 2024.
What is the 52-week low for Ensysce Biosciences Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Ensysce Biosciences Inc 52 week low is $0.512 as of June 05, 2024.
What is Ensysce Biosciences Inc stock price today?
Ensysce Biosciences Inc stock price today is $0.5716.
What was Ensysce Biosciences Inc stock price yesterday?
Ensysce Biosciences Inc stock price yesterday was $0.592.
What is the PE ratio of Ensysce Biosciences Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Ensysce Biosciences Inc’s P/E ratio is -0.16.
What is the Price-to-Book ratio of Ensysce Biosciences Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Ensysce Biosciences Inc P/B ratio is 1.1174.
What is Ensysce Biosciences Inc's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Ensysce Biosciences Inc's EBITDA is -0.10.
What is the 50-day moving average of Ensysce Biosciences Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Ensysce Biosciences Inc 50-day moving average is $0.6478.
How many employess does Ensysce Biosciences Inc has?